Monitoring Investments of Ruane, Cunniff, & Goldfarb - Q1 2025 Overview
Analyzing Quarterly Shifts in Ruane, Cunniff & Goldfarb's 13F Portfolio
Welcome to another installment of our ongoing series, where we delve into the modifications made to Ruane, Cunniff & Goldfarb's 13F portfolio on a regular basis. This latest analysis is based on the regulatory 13F Form, filed on May 15, 2025.
Let's dive in!
Key Alterations
Recent adjustments to the portfolio include a decrease in its value, which now stands at around $5.51 billion, with 38 total holdings[1][2]. Some of the top players in this portfolio include The Charles Schwab Corporation, Formula One Group (Liberty Media), Elevance Health, Inc., Intercontinental Exchange, Inc., and UnitedHealth Group Incorporated[2].
Alongside these mainstays, the portfolio has also introduced new positions. These include Vanguard Index Funds - Vanguard S&P 500 ETF and Vanguard STAR Funds - Vanguard Total International Stock ETF[2].
These changes underscore the firm's evolving approach and investment focus as unveiled in their recent SEC filings. However, the specifics of these changes, such as reductions or additions in specific stocks, aren't explicitly laid out in the available information.
[1] [Source]
[2] [Source]
The firm, Ruane, Cunniff & Goldfarb, has reduced its business value in their 13F portfolio, currently totaling approximately $5.51 billion, and has also introduced new positions in investing, such as Vanguard Index Funds - Vanguard S&P 500 ETF and Vanguard STAR Funds - Vanguard Total International Stock ETF.
Despite recent alterations in their finance and investing strategies, the specifics of the changes in individual stocks within these holdings remain undisclosed in the available information.